Latest News in the pharma Industry

Top Stories

Japan's Santen to Acquire French Novagali

Japan's Santen to Acquire French Novagali

29 Sep 2011

Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French biopharma Novagali.

Read more 
Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement

Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement

29 Sep 2011

Helsinn Healthcare and Riemser Arzneimittel signed an agreement to grant marketing rights in Germany to Riemser for a next-generation treatment in development for the prevention of chemotherapy-induced nausea and vomiting.

Read more 
AmerisourceBergen to Acquire TheraCom for $250M

AmerisourceBergen to Acquire TheraCom for $250M

28 Sep 2011

Pharmaceutical wholesaler AmerisourceBergen has agreed to buy TheraCom, a subsidiary of CVS Caremark, for $250 million.

Read more 
Biotie Therapies to Acquire Newron for €45M

Biotie Therapies to Acquire Newron for €45M

28 Sep 2011

Finnish biotech Biotie Therapies will purchase Italian biopharmaceutical firm Newron Pharmaceuticals for €45m.

Read more 
Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products

Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products

28 Sep 2011

Lonza has entered into a strategic alliance with Australia-based Mesoblast for the production of Mesoblast's adult stem cell therapies.

Read more 
PCCA Urges Member Pharmacists to Offer Solutions for Drug Shortages

PCCA Urges Member Pharmacists to Offer Solutions for Drug Shortages

28 Sep 2011

PCCA President urges member pharmacists to continue their efforts to reduce the growing issue of drug shortages.

Read more 
Merck Opens R&D Facility in Ireland

Merck Opens R&D Facility in Ireland

26 Sep 2011

Six drugs are currently in development at the facility, including Merck's candidate drug for the treatment of hepatitis C and a dual high cholesterol/type II diabetes medication.

Read more 
SK Biopharmaceuticals with Mayo Clinic for Sclerosis Drug Development

SK Biopharmaceuticals with Mayo Clinic for Sclerosis Drug Development

26 Sep 2011

The South Korean biotech forms a partnership with Mayo Clinic to focus on research into chemical compounds that target a type of protein known as TDP-43.

Read more 
Loxbridge with Nobel Prize Winner to Combat Superbugs

Loxbridge with Nobel Prize Winner to Combat Superbugs

26 Sep 2011

Loxbridge Research signed a joint venture agreement to form Altermune Technologies to develop new therapeutics targeting combat resistant pathogens.

Read more 
BMS & Ambrx Form Collaboration in Two Therapeutic Areas

BMS & Ambrx Form Collaboration in Two Therapeutic Areas

23 Sep 2011

New York-based Bristol-Myers Squibb has inked an agreement with Ambrx to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein and the Relaxin hormone.

Read more 
India's Drug Regulators to Send Delegation to Inspect Manufacturing Sites in China

India's Drug Regulators to Send Delegation to Inspect Manufacturing Sites in China

23 Sep 2011

This will be the second auditing and inspection of manufacturing facilities in China. The CDSCO delegation inspected five manufacturing sites in China in May which have been found to be in good condition.

Read more 
Lilly Invests $30M in Partnership to Address Chronic Diseases

Lilly Invests $30M in Partnership to Address Chronic Diseases

22 Sep 2011

The partnership will initially focus on diabetes - a core business area in which Lilly has deep expertise.

Read more